Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2021, Vol. 53 ›› Issue (6): 1049-1054. doi: 10.19723/j.issn.1671-167X.2021.06.007

Previous Articles     Next Articles

Analysis of cervical instability and clinical characteristics in treatment-naive rheumatoid arthritis patients

ZHANG Lu1,HU Xiao-hong2,CHEN Cheng1,CAI Yue-ming1,WANG Qing-wen1,ZHAO Jin-xia3,△()   

  1. 1. Department of Rheumatology & Immunology, Shenzhen 518036, Guangdong, China
    2. Department of medical imaging, Peking University Shenzhen Hospital, Shenzhen 518036, Guangdong, China
    3. Department of Rheumatology & Immunology, Peking University Third Hospital, Beijing 100191, China
  • Received:2021-06-24 Online:2021-12-18 Published:2021-12-13
  • Contact: Jin-xia ZHAO E-mail:zhao-jinxia@163.com

RICH HTML

 13   

PDF (PC)

188

Abstract:

Objective: To study the proportion of cervical spine instability in treatment-naive rheumatoid arthritis (RA) patients, to investigate the associated neck symptoms, and to analyze the clinical characteristics in treatment-naive RA patients and treated RA patients. Methods: RA patients who underwent cervical spine X-ray imaging from the Department of Rheumatology and Immunology of Peking University Third Hospital and Peking University Shenzhen Hospital from August 2015 to October 2019 and had clinical records of medication administration were included. Clinical and laboratory data including cervical symptoms and X-ray imaging data of cervical spine were collected. The constituent ratio of cervical spine instability in treatment-naive RA patients was statistically analyzed. The clinical data and laboratory data were analyzed by t-test, u-test and chi square to explore the clinical characteristics of the treatment-naive RA patients with cervical instability. Results: Of the 408 RA patients, 105 patients were treatment-naive. Of the 105 treatment-naive patients, 82.9% (87/105) were female, with an average age of (52±14) years, the median duration of the disease was 24 months, the shortest history was 2 weeks, and the longest history was 30 years. 28.6% (30/105) of the treatment-naive RA patients showed cervical spine instability. The prevalence of cervical instability was 13.6% in the treatment-naive RA patients with disease duration less than 24 months. Among them, there were no significant differences in neck symptoms between cervical spine instability group and none cervical spine instability group. The patients with cervical spine instability had a longer duration of disease [60 (18,180) months vs.16 (8,51) months], a higher proportion of peripheral joint deformity (63.3%vs.21.3%), and a lower hemoglobin [(106.90±21.61) g/L vs. (115.77±14.69) g/L]. There was no significant difference in the occurrence of cervical instability in the treatment-naive RA patients compared with treated RA patients. Among the RA patients with cervical instability, there was no statistically significant difference in the composition of each type between the patients with treatment-naive RA and patients with treated RA, except for a shorter duration of disease [120.0 (72.0, 240.0) months vs. 60.0 (27.0, 167.5) months]. Conclusion: 28.6% of treatment-naive RA patients showed cervical spine instability. Cervical instability was also common in RA patients with a duration less than 24 months. There was no significant correlation between cervical instability and neck symptoms. Patients with cervical spine instability had a long-term disease, a higher proportion of peripheral joint deformity and a lower hemoglobin. Controlling the condition of RA early may help to control the progression of cervical involvement in patients with RA.

Key words: Rheumatoid arthritis, Cervical spine instability, Peripheral joint deformity, Neck symptom

CLC Number: 

  • R593.22

Figure 1

Cervical dynamic X-ray in RA patients with combined anterior atlantoaxial subluxation A, extend excessive position; B, neutral position; C, bend excessive position. AADI, anterioratlanto-odontoidinterval."

Table 1

Comparison of clinical characteristics of initial treatment RA patients with cervical spine instability and none cervical spine instability"

Items Cervical spine instability group(n=30) None cervical spine instability group(n=75) P
Female, n(%) 28 (93.3) 59 (78.7) 0.072
Age/years, $\overline{x}$±s 50.57±14.41 52.73±13.43 0.466
Course of disease/months, M (P25, P75) 60 (18,180) 16 (8,51) 0.002
Swollen joints, M (P25, P75) 2 (1,7) 2 (2,7) 0.408
Tender joints, M (P25, P75) 5 (3,11) 4 (1,9) 0.241
Peripheral joint malformations, n(%) 19 (63.3) 16 (21.3) <0.001
VAS measuring general health score, $\overline{x}$±s 5.12±2.20 4.26±2.29 0.083
DAS28-ESR score, $\overline{x}$±s 4.81±1.32 4.53±1.56 0.407
Anti-CCP positive, n(%) 27 (93.1) 60 (80.0) 0.105
RF positive, n(%) 27 (93.1) 62 (83.8) 0.214
High CRP levels, n(%) 15 (51.7) 44 (62.0) 0.344
ESR/(mm/h), M (P25, P75) 28.0 (12.5,64.0) 29.5 (20.0, 53.5) 0.468
WBC/(×109/L), $\overline{x}$±s 6.05±2.04 6.58±2.02 0.228
HGB/(g/L), $\overline{x}$±s 106.90±21.62 115.77±14.69 0.045
PLT/(×109/L), $\overline{x}$±s 292.13±120.96 288.96±88.38 0.882

Table 2

Comparison of clinical characteristics of initial treatment RA patients and treated RA patients in RA patients with cervical spine instability"

Items Treated(n=97) Initial treatment(n=30) P
Female, n(%) 76 (78.4) 28 (93.3) 0.112
Age (years), M (P25, P75) 57.0 (46.0, 64.0) 53.0 (38.5, 58.0) 0.178
Course of disease/months, M (P25, P75) 120.0 (72.0, 240.0) 60.0 (27.0, 167.5) 0.019
Neck symptoms, n(%) 33 (34.4) 16 (55.2) 0.073
DAS28-ESR score, $\overline{x}$±s 4.9±1.8 4.8±1.3 0.831
Swollen joints, M (P25, P75) 3.0 (0.0, 9.0) 2.5 (1.0, 7.5) 0.828
Tender joints, M (P25, P75) 5.0 (1.0, 15.0) 5.5 (3.0, 11.5) 0.778
Peripheral joint malformations, n(%) 57 (58.8) 19 (63.3) 0.816
VAS measuring general health score, $\overline{x}$±s 4.8±2.6 5.1±2.2 0.517
Anti-CCP positive, n(%) 81 (91) 27 (93.1) 0.999
ESR/(mm/h), M (P25, P75) 38.0 (18.0, 61.0) 28.0 (13.0, 60.0) 0.289
High CRP levels, n(%) 66 (71.0) 15 (51.7) 0.091
RF positive, n(%) 72 (77.4) 27 (93.1) 0.107
WBC/(×109/L), $\overline{x}$±s 6.5±2.5 6.1±2.0 0.392
Hgb/(g/L), $\overline{x}$±s 111.4±17.8 106.9±21.6 0.250
PLT/(×109/L), $\overline{x}$±s 285.7±108.1 292.1±121.0 0.783
[1] Yang SY, Boniello AJ, Poorman CE, et al. A review of the diagnosis and treatment of atlantoaxial dislocations[J]. Global Spine, 2014, 4(3):197-210.
[2] Olinger CR, Bransford R. Upper cervical trauma[J]. Orthop Clin North Am, 2021, 52(4):451-479.
doi: 10.1016/j.ocl.2021.05.013
[3] Hedequist D, Bekelis K, Emans J, et al. Single stage reduction and stabilization of basilar invagination after failed prior fusion surgery in children with Down’s syndrome[J]. Spine (Phila Pa 1976), 2010, 35(4):E128-133.
doi: 10.1097/BRS.0b013e3181bad0c2
[4] 张璐, 刘湘源. 不可忽视类风湿关节炎的颈椎受累[J]. 中华风湿病学杂志, 2015, 19(4):217-218.
[5] 张璐, 胡小红, 王庆文, 等. 类风湿关节炎合并颈椎失稳的人群分布及临床特征[J]. 北京大学学报(医学版), 2020, 52(6):50-55.
[6] Bodakçi E, Üsküdar CD, Ertürk A, et al. Can neck pain be an initial symptom of rheumatoid arthritis? A case report and literature review[J]. Rheumatol Int, 2018, 38(5):925-931.
doi: 10.1007/s00296-018-4019-z pmid: 29589114
[7] Baek IW, Joo YB, Park KS, et al. Risk factors for cervical spine instability in patients with rheumatoid arthritis[J]. Clin Rheumatol, 2021, 40(2):547-555.
doi: 10.1007/s10067-020-05243-9
[8] Mori Y, Izumiyama T, Baba K, et al. Evaluation of risk factors of vertebral fracture in Japanese female patients with glucocorticoid-induced osteoporosis[J]. J Orthop Surg Res, 2020, 15(1):290.
doi: 10.1186/s13018-020-01813-4 pmid: 32727595
[9] Sandström T, Rantalaiho V, Yli-Kerttula T, et al. Cervical spine involvement among patients with rheumatoid arthritis treated actively with treat-to-target strategy: 10-year results of the NEO-RACo study[J]. J Rheumatol, 2020. 47(8):1160-1164.
doi: 10.3899/jrheum.190139 pmid: 31732558
[10] Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative[J]. Ann Rheum Dis, 2010, 69(9):1580-1588.
doi: 10.1136/ard.2010.138461 pmid: 20699241
[11] Joaquim AF, Ghizoni E, Tedeschi H, et al. Radiological evaluation of cervical spine involvement in rheumatoid arthritis[J]. Neurosurg Focus, 2015, 38(4):E4.
[12] Shlobin NA, Dahdaleh NS. Cervical spine manifestations of rheumatoid arthritis: A review[J]. Neurosurg Rev, 2021, 44(4):1957-1965.
doi: 10.1007/s10143-020-01412-1
[13] Drosos AA, Pelechas E, Voulgari PV. Radiological findings of the cervical spine in rheumatoid arthritis: What a rheumatologist should know[J]. Curr Rheumatol Rep, 2020, 22(6):19.
doi: 10.1007/s11926-020-00894-8
[14] Zhang T, Pope J. Cervical spine involvement in rheumatoid arthritis over time: Results from a meta-analysis[J]. Arthritis Res Ther, 2015, 17(1):148.
doi: 10.1186/s13075-015-0643-0
[15] Mańczak M, Gasik R. Cervical spine instability in the course of rheumatoid arthritis-imaging methods[J]. Reumatologia, 2017, 55(4):201-207.
[16] Zhu S, Xu W, Luo Y, et al. Cervical spine involvement risk factors in rheumatoid arthritis: A meta-analysis[J]. Int J Rheum Dis, 2017, 20(5):541-549.
doi: 10.1111/apl.2017.20.issue-5
[17] Na MK, Chun HJ, Bak KH, et al. Risk factors for the development and progression of atlantoaxial subluxation in surgically treated rheumatoid arthritis patients, considering the time interval between rheumatoid arthritis diagnosis and surgery[J]. J Korean Neurosurg Soc, 2016, 59(6):590-596.
doi: 10.3340/jkns.2016.59.6.590
[18] Möller B, Everts-graber J, Florentinus S, et al. Low hemoglobin and radiographic damage progression in early rheumatoid arthritis: secondary analysis from a phase Ⅲ trial[J]. Arthritis Care Res (Hoboken), 2018, 70(6):861-868.
doi: 10.1002/acr.v70.6
[1] GAO Chao,CHEN Li-hong,WANG Li,YAO Hong,HUANG Xiao-wei,JIA Yu-bo,LIU Tian. Validation of the Pollard’s classification criteria (2010) for rheumatoid arthritis patients with fibromyalgia [J]. Journal of Peking University (Health Sciences), 2022, 54(2): 278-282.
[2] LUO Liang,HUO Wen-gang,ZHANG Qin,LI Chun. Clinical characteristics and risk factors of rheumatoid arthritis with ulcerative keratitis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1032-1036.
[3] ZHONG Hua,XU Li-ling,BAI Ming-xin,SU Yin. Effect of chemokines CXCL9 and CXCL10 on bone erosion in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1026-1031.
[4] LOU Xue,LIAO Li,LI Xing-jun,WANG Nan,LIU Shuang,CUI Ruo-mei,XU Jian. Methylation status and expression of TWEAK gene promoter region in peripheral blood of patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1020-1025.
[5] CAO Di,WANG Yan,WANG Liu-qing,SUN Xiao-lin,HUANG Fei,MENG Yang,REN Li-li,ZHANG Xue-wu. Expression of plasma Dickkopf-1 in patients with rheumatoid arthritis and its correlation with peripheral blood T cell subsets [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 255-260.
[6] ZHAO Kai,CHANG Zhi-fang,WANG Zhi-hua,PANG Chun-yan,WANG Yong-fu. Therapeutic effect of gene silencing peptidyl arginine deaminase 4 on pulmonary interstitial lesions induced by collagen-induced arthritis mice [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 235-239.
[7] Jia-li CHEN,Yue-bo JIN,Yi-fan WANG,Xiao-ying ZHANG,Jing LI,Hai-hong YAO,Jing HE,Chun LI. Clinical characteristics and risk factors of cardiovascular disease in patients with elderly-onset rheumatoid arthritis: A large cross-sectional clinical study [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1040-1047.
[8] Lu ZHANG,Xiao-hong HU,Qing-wen WANG,Yue-ming CAI,Jin-xia ZHAO,Xiang-yuan LIU. Population distribution and clinical characteristics in rheumatoid arthritis patients with cervical spine instability [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1034-1039.
[9] Guo TANG,Li LONG,Ya-xin HAN,Qing PENG,Jia-jun LIU,Hua SHANG. Clinical characteristics and related factors of rheumatoid arthritis complicated with tuberculosis infection [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1029-1033.
[10] Jing-feng ZHANG,Xiu-ling YE,Meng DUAN,Xiao-li ZHOU,Zhong-qiang YAO,Jin-xia ZHAO. Clinical and laboratory characteristics of rheumatoid arthritis with positive antinuclear antibody [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1023-1028.
[11] Jia-jing PENG,Tian LIU. Rheumatoid arthritis combined with pigmented villonodular synovitis: A case report and literature review [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1135-1139.
[12] Cai-nan LUO,Zheng-fang LI,Li-jun WU,Hai-juan CHEN,Chun-mei YANG,Wen-hui XU,Xiao-ling LIU,Wei TANG,Ping QIAO,Baihetiya Rena. Multicenter performance of the different classification criteria for rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2020, 52(5): 897-901.
[13] Hong ZHU,Li-juan ZHAO,Yan ZHOU,Yao CHEN. Significance of anti-carbamylated protein antibodies in patients with rheumatoid arthritis-associated intersitial lung disease [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1003-1007.
[14] Xiao-ying ZHANG,Jia-yang JIN,Jing HE,Yu-zhou GAN,Jia-li CHEN,Xiao-zhen ZHAO,Jia-jia LIU,Xu-jie YOU,Xue LI,Jian-ping GUO,Xiao-feng LI,Jing LI,Ru LI,Zhan-guo LI. Family history of rheumatic diseases in patients with rheumatoid arthritis: a large scale cross-sectional study [J]. Journal of Peking University(Health Sciences), 2019, 51(3): 439-444.
[15] Li WANG,Chao GAO,Di ZHU,Li-hong CHEN. Effect of functional exercises on patients with rheumatoid arthritis: a meta-analysis [J]. Journal of Peking University(Health Sciences), 2018, 50(6): 991-997.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] Author. English Title Test[J]. Journal of Peking University(Health Sciences), 2010, 42(1): 1 -10 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 188 -191 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 376 -379 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 459 -462 .
[5] . [J]. Journal of Peking University(Health Sciences), 2010, 42(1): 82 -84 .
[6] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 319 -322 .
[7] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 333 -336 .
[8] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 337 -340 .
[9] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 225 -328 .
[10] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 346 -350 .
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd